Attention deficit / hyperactivity disorder, abbreviated ADHD and AD / HD, is a psychiatric diagnosis from the U.S. diagnostic system DSM-IV.
Conditions may turn out differently, but are characterized by different degrees and the combination of attention deficit, impulsivity and hyperactivity. It is innate and occurs both in children and adults, men and women. ADHD was first described in medical literature in 1899 and 1902. The diagnosis was formerly called MBD (short for Minimal Brain Dysfunction, meaning “extremely small dysfunction brain “), but since you have not been able to find any particular dysfunction or damage in the brain, has passed away from this diagnosis.
It has been found that children with ADHD have reduced the effect of the neurotransmitter dopamine in the brain, but there is debate about this should be interpreted as a deviation from the norm.
ADHD is an independent research organisation formed to investigate and evaluate adverse effects and contraindications of drug used in treating ADHD (Attention Deficit Hyperactivity Disorder) . Our organisation is a non-profit and submits to making all findings freely available on our website.
- Unable to concentrate at school?
- Finding it difficult to read for more than a few minutes?
- Often sick?
- Generally disorganised?
- Easily frustrated?
- Struggling with social interaction?
- Do you have any of the above ones?
- Is it difficult to keep a job?
- Are you often distracted?
- Are you always late?
- Is it a struggle to pull things together?
- Is it difficult to complete a project?
Defiance disorder, conduct disorder, anxiety disorders, OCD, sleep disorders and depressive disorders often occur together with AD / HD. In order to diagnose the symptoms must have been present for at least 6 months, they must have made his debut before 7 years of age, and it must not be any other diagnosis or condition that better explains the difficulties. There may be many reasons for concentration problems, impulsiveness and hyperactivity in children, adolescents and adults, and it can therefore sometimes be difficult to make the correct diagnosis quickly.
In South Africa, used the term DAMP, Deficit in Attention, Motor Control and Perception, which include motor clumsiness. Children or adults who only have attention disorder and not hyperactivity, can be diagnosed with Attention Deficit Disorder (ADD).
Diagnosis usually occurs after the observations, the use of assessment tools and various tests. It is also under investigation common to interview or otherwise collect information from parents, teachers or other important people around the patient suspected to have ADHD.
It has also developed tests for head movements, OPTAX and eye movements, Pavlidis test that has been used to supplement the study of ADHD.
Difficult social and / or psychological problems in or around the patient can significantly contribute to worsen the ADHD condition. Many of the patients also demonstrated different sleep disorders, and must be treated for these.
Follow-up studies show that untreated ADHD increases the risk for a variety of issues. It is a doubled risk of substance abuse. The incidence of severe behavioral disorders, depression, anxiety and other psychiatric disorders are also increased.
Some also report having good effect on the ADHD symptoms of using omega-3 fatty acids.
Strattera has a behavior more similar to antidepressants of the SSRI type, and therefore longer-lasting effect.
In many cases, treatment with methylphenidate or atomoxetine provide good symptom relief also for the additional suffering, but sometimes it may be necessary also to use more specific drugs to alleviate these.
The clinical experience with metylphenidat spanning more than 80 years, and therefore well known to both efficacy and side effects of the drug. Atomoxetine is a relatively new agent, and both efficacy and side effect profile is more uncertain. It is known that in some drug can cause rare but serious leverskade. It is therefore very important to monitor liver function with blood tests the first time after starting the drug. Several studies and clinical practice suggest that methylphenidate improves symptom relief by strong motility, while atomoxetine may provide sufficient power if the concentration and / or processing of information is the main problem.
Clonidine may improve symptoms of ADHD, compared with placebo, but we’re not sure the difference is of importance for the patient. Treatment with Clonidine can cause low heart rate.
Medications that treat ADHD have long been a controversial topic. The research behind medicines are often funded by pharmaceutical companies have vested interest in getting medication for this disorder on the market. It has been shown that studies funded by pharmaceutical companies, which do not show beneficial effect of medication, many times will not be published . Therefore, there may be reason to look at the supposed beneficial effects of the drugs with some skepticism. A so-called significant effect means that the effect is measurable and can involve as few as 1-2 of 100 drug users have a beneficial effect of the medication. Then it is 98 -99 people who do not have power. Several meta-analysis done by the most common medications for ADHD, has often proved to have significantly higher power than mock medications. At the same time in recent years carried out studies showing that drug treatment of ADHD is ineffective for a long time.
Since ADHD over a few years is set as a diagnosis in more and more patients with possibly lighter degrees of the disease, the drug appears less effective and there is a greater risk of serious, are not acceptable side effects. These effects can be seen in relation to most conditions and its treatments.
Diagnosis has historically primarily been associated with children and young people, as it turns out that the symptoms of many curbs or changes with age and maturity.
Many adults also achieves an improvement because they learn coping strategies. Yet there are many adults who have ADHD or who have confirmed diagnosis until adulthood. Many of these will benefit from drug therapy.
As a rule, the treatment included a combination of several measures at once: Medical treatment, behavioral therapy (children), psychosocial , and adaptation to
school / work and at home.
A lengthy study in the United States (“MTA Study”) showed that drug treatment improves symptoms and school performance in children with ADHD. Behavior-oriented treatment alone had little effect, while treatment and behavioral therapy in combination gave the best effect.